[go: up one dir, main page]

IL136735A0 - Substituted 2-benzylamino-2-phenyl-acetamide compounds - Google Patents

Substituted 2-benzylamino-2-phenyl-acetamide compounds

Info

Publication number
IL136735A0
IL136735A0 IL13673598A IL13673598A IL136735A0 IL 136735 A0 IL136735 A0 IL 136735A0 IL 13673598 A IL13673598 A IL 13673598A IL 13673598 A IL13673598 A IL 13673598A IL 136735 A0 IL136735 A0 IL 136735A0
Authority
IL
Israel
Prior art keywords
benzylamino
phenyl
substituted
acetamide compounds
compounds
Prior art date
Application number
IL13673598A
Other languages
English (en)
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Publication of IL136735A0 publication Critical patent/IL136735A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13673598A 1997-12-31 1998-12-12 Substituted 2-benzylamino-2-phenyl-acetamide compounds IL136735A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9727521.8A GB9727521D0 (en) 1997-12-31 1997-12-31 Substituted 2-benzylamino-2-phenyl-acetamide compounds
PCT/EP1998/008158 WO1999035123A1 (en) 1997-12-31 1998-12-12 Substituted 2-benzylamino-2-phenyl-acetamide compounds

Publications (1)

Publication Number Publication Date
IL136735A0 true IL136735A0 (en) 2001-06-14

Family

ID=10824340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13673598A IL136735A0 (en) 1997-12-31 1998-12-12 Substituted 2-benzylamino-2-phenyl-acetamide compounds

Country Status (22)

Country Link
US (1) US6303819B1 (xx)
EP (1) EP1044186B9 (xx)
JP (1) JP3839665B2 (xx)
KR (1) KR100629628B1 (xx)
AT (1) ATE319680T1 (xx)
BG (1) BG64700B1 (xx)
CA (1) CA2316082C (xx)
CZ (1) CZ296722B6 (xx)
DE (1) DE69833797T2 (xx)
EA (1) EA003097B1 (xx)
ES (1) ES2256976T3 (xx)
GB (1) GB9727521D0 (xx)
HR (1) HRP20000508B9 (xx)
HU (1) HUP0100184A3 (xx)
ID (1) ID26622A (xx)
IL (1) IL136735A0 (xx)
NO (1) NO327259B1 (xx)
NZ (1) NZ505441A (xx)
PL (1) PL194745B1 (xx)
PT (1) PT1044186E (xx)
TR (1) TR200001950T2 (xx)
WO (1) WO1999035123A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
NZ525892A (en) * 2000-11-27 2004-11-26 Pharmacia Italia S Phenylacetamido- pyrazole derivatives their use as antitumor agents and preparation process thereof
ATE317280T1 (de) * 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
WO2004087125A1 (en) * 2003-04-02 2004-10-14 Ionix Pharmaceuticals Limited Amino acid derivatives as inhibitors of mammalian sodium channels
EP1524267A1 (en) * 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Substituted benzylaminoalkylene heterocycles
EP1680127B1 (en) 2003-10-23 2008-10-15 F. Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
EP1533302A1 (en) * 2003-11-21 2005-05-25 Newron Pharmaceuticals S.p.A. Histidine derivatives
EP1533298A1 (en) * 2003-11-21 2005-05-25 Newron Pharmaceuticals S.p.A. 3-aminopyrrolidone derivatives
EP1535908A1 (en) * 2003-11-24 2005-06-01 Newron Pharmaceuticals S.p.A. N-acyl-N'-benzyl-alkylendiamino drivatives
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
NZ567540A (en) * 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
EP1870097A1 (en) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
WO2008107335A1 (en) * 2007-03-05 2008-09-12 F. Hoffmann-La Roche Ag Aminoamides as orexin antagonists
US11111208B2 (en) * 2019-06-17 2021-09-07 RK Pharma Solutions LLC Process for the preparation of safinamide mesylate intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR0147963B1 (ko) * 1995-01-10 1998-08-17 강박광 엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
US5688830A (en) 1996-01-25 1997-11-18 Syntex (U.S.A.) Inc. Treatment of neuropathic pain

Also Published As

Publication number Publication date
GB9727521D0 (en) 1998-02-25
CA2316082C (en) 2006-02-07
PL341514A1 (en) 2001-04-23
PT1044186E (pt) 2006-07-31
HRP20000508A2 (en) 2001-02-28
KR20010033779A (ko) 2001-04-25
HRP20000508B1 (hr) 2007-02-28
NO327259B1 (no) 2009-05-25
WO1999035123A1 (en) 1999-07-15
NZ505441A (en) 2001-12-21
NO20003398D0 (no) 2000-06-29
KR100629628B1 (ko) 2006-09-29
BG104569A (en) 2001-02-28
HRP20000508B9 (hr) 2008-05-31
DE69833797D1 (de) 2006-05-04
BG64700B1 (bg) 2005-12-30
ATE319680T1 (de) 2006-03-15
US6303819B1 (en) 2001-10-16
TR200001950T2 (tr) 2000-11-21
HUP0100184A3 (en) 2002-11-28
EA200000728A1 (ru) 2001-02-26
HUP0100184A2 (hu) 2001-07-30
CA2316082A1 (en) 1999-07-15
JP3839665B2 (ja) 2006-11-01
EP1044186B9 (en) 2006-06-21
HK1028021A1 (en) 2001-02-02
JP2002500214A (ja) 2002-01-08
ID26622A (id) 2001-01-25
EA003097B1 (ru) 2002-12-26
CZ296722B6 (cs) 2006-05-17
DE69833797T2 (de) 2006-10-19
NO20003398L (no) 2000-08-02
EP1044186B1 (en) 2006-03-08
ES2256976T3 (es) 2006-07-16
CZ20002496A3 (cs) 2000-12-13
PL194745B1 (pl) 2007-06-29
EP1044186A1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
IL136735A0 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
MY118904A (en) 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents
AU4523797A (en) Atherosclerosis treatment
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GR3033786T3 (en) Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
GB9300194D0 (en) Piperazine derivatives
AU3744397A (en) Total synthesis of antitumor acylfulvenes
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
WO2003022797A1 (en) Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient
MY123373A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
BG104037A (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
ATE158301T1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DK0998930T3 (da) Azasteroidforbindelser til behandling af alopecia, hirsutisme og seborrhea
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
CA2266565A1 (en) Azabicyclic rotomase inhibitors
ID22762A (id) Komposisi untuk mengobati atau mencegah kanker prostat
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
AU2932500A (en) Compositions containing esters for treating parasitic infestations of organisms
YU79401A (sh) Derivati 1-trifluorometil-4-hidroksi-7-piperidinil- aminometilhromana
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.

Legal Events

Date Code Title Description
HE Change of address of proprietor(s)
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees